Haikala H, Levijoki J, Lindén I B
Orion-Farmos, Orion Research, Espoo, Finland.
J Mol Cell Cardiol. 1995 Oct;27(10):2155-65. doi: 10.1016/s0022-2828(95)91371-8.
The effects of various calcium sensitizers on myosin-actin crossbridge kinetics were evaluated in intact, paced guinea-pig papillary muscle by analysing the velocity of the development of isometric tension (dT/dt) in detail. The effect on association (the whole sequence of events from troponin onward) and dissociation rates of crossbridges was estimated from the rising phase and from the early decay phase of the normalized dT/dt curve. Levosimendan, a calcium sensitizer acting through troponin C, accelerated the proportional association rate and decelerated the dissociation rate of crossbridges. The effect of levosimendan on crossbridge kinetics occurred before the peak twitch tension was achieved. Thus, the compound did not change the actual relaxation phase of twitch tension. Since the effect on the association was more pronounced than on the dissociation of crossbridges, levosimendan shifted the entire twitch tension curve to the left. Based on the dissociation rate analysis levosimendan seems to act preferentially as a calcium sensitizer at low concentrations. At high concentrations the phosphodiesterase III (PDE III) inhibitory properties of levosimendan modulated its effect on the early relaxation processes. In contrast, PDE III inhibition is probably the primary mechanism of action for MCI-154. Pimobendan, and EMD 53998 at low concentrations, whereas their direct effects on crossbridge kinetics contributed to the positive inotropic action at high concentrations. The calcium sensitizing mechanisms of these compounds seemed to be based almost exclusively on the decelerating effect on dissociation of crossbridges.
通过详细分析等长张力发展速度(dT/dt),在完整的、有节律刺激的豚鼠乳头肌中评估了各种钙敏化剂对肌球蛋白 - 肌动蛋白横桥动力学的影响。根据归一化dT/dt曲线的上升阶段和早期衰减阶段,估算了对横桥结合(从肌钙蛋白开始的整个事件序列)和解离速率的影响。左西孟旦是一种通过肌钙蛋白C起作用的钙敏化剂,它加速了横桥的成比例结合速率并减慢了解离速率。左西孟旦对横桥动力学的影响在达到峰值抽搐张力之前就已出现。因此,该化合物并未改变抽搐张力的实际舒张阶段。由于对结合的影响比对横桥解离的影响更明显,左西孟旦将整个抽搐张力曲线向左移动。基于解离速率分析,左西孟旦在低浓度时似乎优先作为钙敏化剂起作用。在高浓度时,左西孟旦的磷酸二酯酶III(PDE III)抑制特性调节了其对早期舒张过程的影响。相比之下,PDE III抑制可能是MCI - 154、匹莫苯丹和低浓度EMD 53998的主要作用机制,而它们在高浓度时对横桥动力学的直接影响促成了正性肌力作用。这些化合物的钙敏化机制似乎几乎完全基于对横桥解离的减速作用。